This Article Full Text Full Text (PDF) All Versions of this Article: 149/1/208    most recent Author Manuscript (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Wang, J. M. Articles by Brinton, R. D. Search for Related Content PubMed PubMed Citation Articles by Wang, J. M. Articles by Brinton, R. D.

Estradiol-17β-Induced Human Neural Progenitor Cell Proliferation Is Mediated by an Estrogen Receptor β-Phosphorylated Extracellularly Regulated Kinase Pathway

Department of Pharmacology and Pharmaceutical Science, School of Pharmacy, and Program in Neuroscience, University of Southern California, Los Angeles, California 90089-9121

Address all correspondence and requests for reprints to: Roberta D. Brinton, Ph.D., Department of Molecular Pharmacology and Toxicology, School of Pharmacy Pharmaceutical Sciences Center, University of Southern California, 1985 Zonal Avenue, Los Angeles, California 90089-9121. E-mail: rbrinton{at}hsc.usc.edu.

Estradiol-17β (E₂) induces rodent hippocampal neural progenitor cell (NPC) proliferation in vitro, in vivo, and after brain injury. The purpose of the present investigation was to determine whether E₂-induced proliferation observed in rodent model systems generalized to cells of human neural origin and the signaling pathway by which E₂ promotes mitosis of human NPCs (hNPCs). Results of these analyses indicate that E₂ induced a significant increase in hNPC proliferation in a time- and dose-dependent manner. E₂-induced hNPC DNA replication was paralleled by elevated cell cycle protein expression and centrosome amplification, which was associated with augmentation of total cell number. To determine whether estrogen receptor (ER) and which ER subtype were required for E₂-induced hNPC proliferation, ER expression was first determined by real-time RT-PCR, followed by Western blot analysis, and subsequently verified pharmacologically using ER or β-selective ligands. Results of these analyses indicated that ERβ expression was predominant relative to ER, which was barely detectable in hNPCs. Activation of ERβ by the ERβ-selective ligand, diarylpropionitrile, led to an increase in phosphorylated extracellular signal-regulated kinase, and subsequent centrosome amplification and hNPC proliferation, which were blocked by the MEKK antagonist, UO126, but not its inactive analog, UO124. These findings, for the first time, demonstrate the molecular cascade and related cell biology events involved in E₂-induced hNPC proliferation in vitro. Therapeutic implications of these findings relevant to hormone therapy and prevention of neurodegenerative disease are discussed.